North America Animal Vaccine Market to Reach $9,788.9 million in 2035, Growing at 7.2% CAGR

North America Animal vaccine market valued at $4,882.1 million in 2025 and is projected to reach $9,788.9 million by 2035, growing at a CAGR of 7.2% during the forecast period (2026-2035). The market comprises biological preparations developed to prevent infectious diseases in livestock and companion animals, ensuring animal health, food safety, and productivity. The market is experiencing steady expansion supported by rising incidence of zoonotic and transboundary animal diseases, growing awareness regarding preventive veterinary care, and stringent government regulations related to food safety and animal disease control. Increasing livestock intensification, expansion of commercial poultry and swine production, and growing investments in advanced recombinant and next-generation vaccine technologies are further strengthening market growth. The adoption of multivalent vaccines and improved cold-chain logistics across North America is also enhancing vaccine coverage and compliance rates.

Browse the full report description of “North America Animal Vaccine Market Size, Share & Trends Analysis Report by Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) Forecast Period, (2026-2035) at https://www.omrglobal.com/industry-reports/north-american-animal-vaccine-market

According to data from the United States Department of Agriculture and the Canadian Food Inspection Agency, large-scale animal health surveillance programs, livestock population monitoring systems, and disease reporting frameworks play a critical role in estimating vaccine demand and managing outbreaks across the region. These institutional datasets support procurement planning, regulatory approvals, and disease prevention strategies in both the United States and Canada.

Key Statistics: North America Animal Vaccines at a Glance

• North America accounts for approximately 32%–35% of the global animal vaccine market revenue, supported by advanced veterinary healthcare infrastructure and high per-animal healthcare spending.
• The United States represents over 85% of regional revenue share, driven by a livestock population exceeding 90 million cattle and more than 75 million swine, alongside a companion animal population surpassing 160 million pets.
• Companion animal vaccines contribute nearly 45% of total regional market revenue, reflecting rising pet insurance coverage and increasing expenditure on preventive veterinary care.

Key Innovators Driving North America Animal Vaccine Transformation

The key players in the North America animal vaccine market Boehringer Ingelheim Animal Health USA Inc., Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Zoetis Inc., among others.

• In June 2025, Zoetis expanded its livestock vaccine portfolio in North America with the introduction of a recombinant swine vaccine intended to provide protection against respiratory diseases in pigs and support herd management outcomes.
• In April 2025, Merck Animal Health introduced a companion animal vaccine platform in the United States incorporating a new adjuvant technology. The platform is designed to support extended immunity duration and safety parameters in veterinary vaccination programs.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Technology
• Competitive Landscape - Boehringer Ingelheim Animal Health USA Inc., Elanco Animal Health Incorporated, Merck & Co., Inc., Phibro Animal Health Corporation, Zoetis Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

North America Animal Vaccine Market Report Segment

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
• Aquaculture Vaccines
• Companion Animal Vaccines
• Other

By Technology

• Live Attenuated Vaccine
• Killed/Inactive Vaccine
• Recombinant Vaccine
• Vectored Vaccine
• Subunit Vaccine
• DNA Vaccine
• Chimeric Vaccine
• Others

North America Animal Vaccine Market Report Segment by Region

• United States
• Canada

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-animal-vaccine-market